A Start-Up Used AI to Create a New Psychedelic — and the Drug Is Out of the Bag
In the rapidly developing crossroads of biotech and AI, one startup is testing what psychedelics can do beyond your classic trip. Traditional psychoactive compounds such as LSD and psilocybin have long been linked with profound, mind-altering hallucinatory experiences. The new company is pushing for delivering the therapeutic benefits from psychedelics...
